EGF-induced adipose tissue mesothelial cells undergo functional vascular smooth muscle differentiation CC Lachaud1

Cell Death and Disease

Volumn 5, Issue 6, 2014, Pages

  Lopez Beas J ^a   Soria, B ^a,b   Hmadcha, A ^a,b  

^a CABIMER Andalusian Center for Molecular Biology and Regenerative Medicine CSIC University of Seville UPO   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BETA1 INTEGRIN; CALDESMON; CALPONIN; CD11B ANTIGEN; CD45 ANTIGEN; COLLAGEN TYPE 1; CONTRACTILE PROTEIN; DESMIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; HERMES ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; MESOTHELIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYOSIN; NESTIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN ZO1; SMAD2 PROTEIN; SMAD3 PROTEIN; SMOOTH MUSCLE ACTIN; STEM CELL ANTIGEN 1; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR GATA 4; UVOMORULIN; VASCULAR CELL ADHESION MOLECULE 1; VIMENTIN;

ADIPOSE TISSUE CELL; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; FEMALE; FIBROBLAST; HEART MUSCLE; IMMUNOFLUORESCENCE; IMMUNOPHENOTYPING; MESOTHELIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SPINDLE CELL; VASCULAR SMOOTH MUSCLE;

EID: 84903791247     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.271     Document Type: Article

References (46)

1. Brenes RA, Bear M, Jadlowiec C, Goodwin M, Hashim P, Protack CD et al. Cell-based interventions for therapeutic angiogenesis: review of potential cell sources. Vascular 2012; 20: 360-368.
2. Raval Z, Losordo DW. Cell therapy of peripheral arterial disease: from experimental findings to clinical trials. Circ Res 2013; 112: 1288-1302.
3. Silvestre JS. Pro-angiogenic cell-based therapy for the treatment of ischemic cardiovascular diseases. Thromb Res 2012; 130(Suppl 1): S90-S94.
4. Ruiz-Salmeron R, de la Cuesta-Diaz A, Constantino-Bermejo M, Perez-Camacho I, Marcos-Sanchez F, Hmadcha A et al. Angiographic demonstration of neoangiogenesis after intra-arterial infusion of autologous bone marrow mononuclear cells in diabetic patients with critical limb ischemia. Cell Transplantat 2011; 20: 1629-1639.
5. Moretti A, Bellin M, Jung CB, Thies TM, Takashima Y, Bernshausen A et al. Mouse and human induced pluripotent stem cells as a source for multipotent isl1+ cardiovascular progenitors. FASEB J 2010; 24: 700-711.
6. Moretti A, Caron L, Nakano A, Lam JT, Bernshausen A, Chen Y et al. Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 2006; 127: 1151-1165.
7. Hmadcha A, Dominguez-Bendala J, Wakeman J, Arredouani M, Soria B. The immune boundaries for stem cell based therapies: problems and prospective solutions. J Cell Mol Med 2009; 13: 1464-1475.
8. Ben-David U, Benvenisty N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat Rev Cancer 2011; 11: 268-277.
9. Lalu MM, McIntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC et al. Safety of cell therapy with mesenchymal stromal cells (safecell): a systematic review and metaanalysis of clinical trials. PLoS One 2012; 7: e47559.
10. Patel P, West-Mays J, Kolb M, Rodrigues JC, Hoff CM, Margetts PJ. Platelet derived growth factor b and epithelial mesenchymal transition of peritoneal mesothelial cells. Matrix Biol 2010; 29: 97-106.
11. Galvez P, Clares B, Hmadcha A, Ruiz A, Soria B. Development of a cell-based medicinal product: regulatory structures in the european union. Br Med Bull 2013; 105: 85-105.
12. Crisan M, Chen CW, Corselli M, Andriolo G, Lazzari L, Peault B. Perivascular multipotent progenitor cells in human organs. Ann N Y Acad Sci 2009; 1176: 118-123.
13. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008; 3: 301-313.
14. Siegel G, Schafer R, Dazzi F. The immunosuppressive properties of mesenchymal stem cells. Transplantation 2009; 87: S45-S49.
15. Pelacho B, Mazo M, Gavira JJ, Prosper F. Adult stem cells: from new cell sources to changes in methodology. J Cardiovasc Transl Res 2011; 4: 154-160.
16. van Tuyn J, Atsma DE, Winter EM, van der Velde-van Dijke I, Pijnappels DA, Bax NA et al. Epicardial cells of human adults can undergo an epithelial-to-mesenchymal transition and obtain characteristics of smooth muscle cells in vitro. Stem Cells 2007; 25: 271-278.
17. Kawaguchi M, Bader DM, Wilm B. Serosal mesothelium retains vasculogenic potential. Dev Dyn 2007; 236: 2973-2979.
18. Lachaud CC, Pezzolla D, Dominguez-Rodriguez A, Smani T, Soria B, Hmadcha A. Functional vascular smooth muscle-like cells derived from adult mouse uterine mesothelial cells. PLoS One 2013; 8: e55181.
19. Rinkevich Y, Mori T, Sahoo D, Xu PX, Bermingham Jr JR, Weissman IL. Identification and prospective isolation of a mesothelial precursor lineage giving rise to smooth muscle cells and fibroblasts for mammalian internal organs, and their vasculature. Nat Cell Biol 2012; 14: 1251-1260.
20. Li Y, Wang J, Asahina K. Mesothelial cells give rise to hepatic stellate cells and myofibroblasts via mesothelial-mesenchymal transition in liver injury. Proc Natl Acad Sci USA 2013; 110: 2324-2329.
21. Chau YY, Bandiera R, Serrels A, Martínez-Estrada OM, Qing W, Lee M et al. Visceral and subcutaneous fat have different origins and evidence supports a mesothelial source. Nat Cell Biol 2014; 16: 367-375.
22. Wada AM, Smith TK, Osler ME, Reese DE, Bader DM. Epicardial/mesothelial cell line retains vasculogenic potential of embryonic epicardium. Circ Res 2003; 92: 525-531.
23. Liu Q, Mao H, Nie J, Chen W, Yang Q, Dong X et al. Transforming growth factor {beta}1 induces epithelial-mesenchymal transition by activating the jnk-smad3 pathway in rat peritoneal mesothelial cells. Perit Dial Int 2008; 28(Suppl 3): S88-S95.
24. Nasreen N, Mohammed KA, Mubarak KK, Baz MA, Akindipe OA, Fernandez-Bussy S et al. Pleural mesothelial cell transformation into myofibroblasts and haptotactic migration in response to tgf-beta1 in vitro. Am J Physiol Lung Cell Mol Physiol 2009; 297: L115-L124.
25. Asahina K, Zhou B, Pu WT, Tsukamoto H. Septum transversum-derived mesothelium gives rise to hepatic stellate cells and perivascular mesenchymal cells in developing mouse liver. Hepatology 2011; 53: 983-995.
26. Mikawa T, Gourdie RG. Pericardial mesoderm generates a population of coronary smooth muscle cells migrating into the heart along with ingrowth of the epicardial organ. Dev Biol 1996; 174: 221-232.
27. Que J, Wilm B, Hasegawa H, Wang F, Bader D, Hogan BL. Mesothelium contributes to vascular smooth muscle and mesenchyme during lung development. Proc Natl Acad Sci USA 2008; 105: 16626-16630.
28. Wilm B, Ipenberg A, Hastie ND, Burch JB, Bader DM. The serosal mesothelium is a major source of smooth muscle cells of the gut vasculature. Development 2005; 132: 5317-5328.
29. Zhou B, Ma Q, Rajagopal S, Wu SM, Domian I, Rivera-Feliciano J et al. Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature 2008; 454: 109-113.
30. Cai CL, Martin JC, Sun Y, Cui L, Wang L, Ouyang K et al. A myocardial lineage derives from tbx18 epicardial cells. Nature 2008; 454: 104-108.
31. Lee MJ, Wu Y, Fried SK. Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications. Mol Aspects Med 2013; 34: 1-11.
32. Christiaens V, Lijnen HR. Angiogenesis and development of adipose tissue. Mol Cell Endocrinol 2010; 318: 2-9.
33. Nishimura S, Manabe I, Nagasaki M, Hosoya Y, Yamashita H, Fujita H et al. Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels. Diabetes 2007; 56: 1517-1526.
34. Lv ZD, Na D, Ma XY, Zhao C, Zhao WJ, Xu HM. Human peritoneal mesothelial cell transformation into myofibroblasts in response to tgf-ss1 in vitro. Int J Mol Med 2011; 27: 187-193.
35. Jain M, He Q, Lee WS, Kashiki S, Foster LC, Tsai JC et al. Role of cd44 in the reaction of vascular smooth muscle cells to arterial wall injury. J Clin Invest 1996; 98: 877.
36. Masaki T. Historical review: endothelin. Trends Pharmacol Sci 2004; 25: 219-224.
37. Ha H, Yu MR, Lee HB. High glucose-induced pkc activation mediates tgf-beta 1 and fibronectin synthesis by peritoneal mesothelial cells. Kidney Int 2001; 59: 463-470.
38. Kang DH, Hong YS, Lim HJ, Choi JH, Han DS, Yoon KI. High glucose solution and spent dialysate stimulate the synthesis of transforming growth factor-beta1 of human peritoneal mesothelial cells: effect of cytokine costimulation. Perit Dial Int 1999; 19: 221-230.
39. Ahmed N, Maines-Bandiera S, Quinn MA, Unger WG, Dedhar S, Auersperg N. Molecular pathways regulating egf-induced epithelio-mesenchymal transition in human ovarian surface epithelium. Am J Physiol Cell Physiol 2006; 290: C1532-C1542.
40. Stylianou E, Jenner LA, Davies M, Coles GA, Williams JD. Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 1990; 37: 1563-1570.
41. Kattman SJ, Huber TL, Keller GM. Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev Cell 2006; 11: 723-732.
42. Bu L, Jiang X, Martin-Puig S, Caron L, Zhu S, Shao Y et al. Human isl1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature 2009; 460: 113-117.
43. Oikawa H, Hayashi K, Maesawa C, Masuda T, Sobue K. Expression profiles of nestin in vascular smooth muscle cells in vivo and in vitro. Exp Cell Res 2010; 316: 940-950.
44. Tamama K, Fan VH, Griffith LG, Blair HC, Wells A. Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells. Stem Cells 2006; 24: 686-695.
45. Jang YH, Shin HS, Sun Choi H, Ryu ES, Jin Kim M, Ki Min S et al. Effects of dexamethasone on the tgf-beta1-induced epithelial-to-mesenchymal transition in human peritoneal mesothelial cells. Lab Invest 2013; 93: 194-206.
46. Ksiazek K, Korybalska K, Jorres A, Witowski J. Accelerated senescence of human peritoneal mesothelial cells exposed to high glucose: the role of tgf-beta1. Lab Invest 2007; 87: 345-356.